Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile
Michael Tees MD, MPH

@miketeesmd

Lymphoma Program Director, Colorado Blood Cancer Institute #lymphoma #lymsm #celltherapy #CART #autoimmune #BMT @CBCIDocs @ColoradoBlood 🏳️‍🌈 opinions my own

ID: 1228345170279559168

linkhttp://www.ColoradoBlood.com calendar_today14-02-2020 15:48:18

123 Tweet

242 Followers

283 Following

Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile Photo

Calculators out. Metabolic tumor volume (> 200 cm3) prognosticates. With FLIPI2, another tool in follicular #lymphoma #lymsm #ASH22 ash.confex.com/ash/2022/webpr…

Calculators out. Metabolic tumor volume (> 200 cm3) prognosticates. With FLIPI2, another tool in follicular #lymphoma #lymsm #ASH22 
ash.confex.com/ash/2022/webpr…
Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile Photo

Transplant adult Ph+ALL in CR1? Compelling to wait if able to give peds induction regimen (and TKI)… #ALL #leusm #BMTsm #ASH22 ash.confex.com/ash/2022/webpr…

Transplant adult Ph+ALL in CR1? Compelling to wait if able to give peds induction regimen (and TKI)… #ALL #leusm #BMTsm #ASH22 
ash.confex.com/ash/2022/webpr…
Aaron Logan, MD, PhD, MPhil (@hemedoc) 's Twitter Profile Photo

#ASH22 #leusm Reville: CLIA-Ven is a great regimen but still could benefit from additional optimization due to prolonged cytopenias during consolidation cycles and associated infections.

#ASH22 #leusm Reville: CLIA-Ven is a great regimen but still could benefit from additional optimization due to prolonged cytopenias during consolidation cycles and associated infections.
Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile Photo

Somewhat argues to pre-bridge (pola-R) to get to “2L” #CART #DLBCL. Often have to anyway… #Lymphoma #lymsm #ASH22 Frederick L. Locke ash.confex.com/ash/2022/webpr…

Somewhat argues to pre-bridge (pola-R) to get to “2L” #CART #DLBCL. Often have to anyway… #Lymphoma #lymsm #ASH22 <a href="/DrFredLocke/">Frederick L. Locke</a> ash.confex.com/ash/2022/webpr…
Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile Photo

Yes totally agree. MTX containing induction + TT containing auto #bmtsm for PCNSL & ph3 data proving it! #lymphoma #lymsm #ASH22

NMDP (@nmdp_org) 's Twitter Profile Photo

What a special moment on Good Morning America this morning when Robin Roberts surprised the nurses who were by her side 10 years ago during her bone marrow transplant journey. 💙💚 Check out their heartwarming reunion 👇

Naveen Pemmaraju, MD (@doctorpemm) 's Twitter Profile Photo

👉👉👉Just out in Blood Advances Lee by our own Dr Nitin Jain Nitin Jain & Dr Bill Wierda Bill Wierda, MD, PhD ➡️ Ph2 results Nivo+IBR for patients with DLBCL-RT of CLL. @MDAndersonNews #leusm #endcancer doi.org/10.1182/blooda… 📣

👉👉👉Just out in <a href="/BloodAdvances/">Blood Advances</a> Lee by our own Dr Nitin Jain <a href="/NitinJainMD/">Nitin Jain</a> &amp; Dr Bill Wierda <a href="/wwierda/">Bill Wierda, MD, PhD</a> ➡️ Ph2 results Nivo+IBR for patients with DLBCL-RT of CLL. @MDAndersonNews #leusm #endcancer 
doi.org/10.1182/blooda… 📣
Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile Photo

Clinical trials are a lifeline for cancer patients. But for too many, they're out of reach. Congress can help ensure that all patients have access to trials. Tell your lawmakers to act now – before it's too late ⌛ advocacy.lls.org/a/nih-clinical… #LLSAction

Clinical trials are a lifeline for cancer patients. But for too many, they're out of reach. Congress can help ensure that all patients have access to trials. Tell your lawmakers to act now – before it's too late ⌛ advocacy.lls.org/a/nih-clinical… #LLSAction
Michael Tees MD, MPH (@miketeesmd) 's Twitter Profile Photo

Clinical trials are a lifeline for cancer patients. But for many—especially patients in underrepresented groups—they’re out of reach. Urge lawmakers to support the NIH Clinical Trial Diversity Act to ensure all patients get the care they need: advocacy.lls.org/a/nih-clinical… #LLSAction

Clinical trials are a lifeline for cancer patients. But for many—especially patients in underrepresented groups—they’re out of reach. Urge lawmakers to support the NIH Clinical Trial Diversity Act to ensure all patients get the care they need: advocacy.lls.org/a/nih-clinical… #LLSAction